Cathie Wood Syros Pharmaceuticals, Inc. Transaction History

Ark Investment Management LLC

  • $10.5 Billion
  • Q3 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021
SELL
$5.01 - $7.48 $38.6 Million - $57.7 Million
-7,711,724 Closed
0 $0
Q1 2021

May 13, 2021
SELL
$7.19 - $14.95 $9.56 Million - $19.9 Million
-1,329,597 Reduced 14.71%
7,711,724 $57.7 Million
Q4 2020

Feb 12, 2021
SELL
$6.66 - $14.66 $14.5 Million - $31.8 Million
-2,171,185 Reduced 19.36%
9,041,321 $98.1 Million
Q3 2020

Oct 30, 2020
BUY
$8.69 - $14.47 $23.5 Million - $39.1 Million
2,699,373 Added 31.71%
11,212,506 $99.1 Million
Q2 2020

Aug 11, 2020
BUY
$5.21 - $11.03 $13.6 Million - $28.8 Million
2,613,735 Added 44.31%
8,513,133 $90.8 Million
Q1 2020

May 14, 2020
BUY
$4.46 - $9.2 $3.66 Million - $7.56 Million
821,591 Added 16.18%
5,899,398 $35 Million
Q4 2019

Jan 31, 2020
BUY
$4.52 - $10.1 $5.62 Million - $12.6 Million
1,243,079 Added 32.42%
5,077,807 $35.1 Million
Q3 2019

Nov 12, 2019
BUY
$7.14 - $11.65 $306,820 - $500,623
42,972 Added 1.13%
3,834,728 $39.8 Million
Q2 2019

Jul 30, 2019
BUY
$5.5 - $9.75 $4.39 Million - $7.79 Million
799,056 Added 26.7%
3,791,756 $35.1 Million
Q1 2019

May 13, 2019
BUY
$5.51 - $9.59 $2.93 Million - $5.1 Million
532,079 Added 21.62%
2,992,700 $27.4 Million
Q4 2018

Feb 01, 2019
BUY
$5.55 - $11.34 $1.33 Million - $2.71 Million
238,751 Added 10.75%
2,460,621 $13.7 Million
Q3 2018

Nov 07, 2018
BUY
$9.74 - $12.92 $4.11 Million - $5.46 Million
422,317 Added 23.47%
2,221,870 $26.5 Million
Q2 2018

Aug 07, 2018
BUY
$10.16 - $13.65 $2.99 Million - $4.02 Million
294,663 Added 19.58%
1,799,553 $18.4 Million
Q1 2018

May 14, 2018
BUY
$9.47 - $12.98 $6.35 Million - $8.7 Million
670,133 Added 80.28%
1,504,890 $19.5 Million
Q4 2017

Feb 12, 2018
BUY
$8.45 - $17.48 $5.92 Million - $12.2 Million
700,058 Added 519.72%
834,757 $8.12 Million
Q3 2017

Nov 09, 2017
BUY
$13.52 - $23.75 $1.58 Million - $2.78 Million
116,994 Added 660.8%
134,699 $1.98 Million
Q2 2017

Aug 11, 2017
BUY
N/A
9,460 Added 114.74%
17,705 $285,000
Q1 2017

May 15, 2017
BUY
N/A
4,774 Added 137.54%
8,245 $131,000
Q4 2016

Feb 13, 2017
BUY
N/A
3,471
3,471 $42,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track Cathie Wood's Portfolio

Track Cathie Wood Portfolio

Follow Cathie Wood (Ark Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email